---
input_text: 'Cerebral hemodynamics and oxygenation in adult patients with sickle cell
  disease after stem cell transplantation. Sickle cell disease (SCD) is characterized
  by chronic hemolytic anemia associated with impaired cerebral hemodynamics and oxygen
  metabolism. Hematopoietic stem cell transplantation (HSCT) is currently the only
  curative treatment for patients with SCD. Whereas normalization of hemoglobin levels
  and hemolysis markers has been reported after HSCT, its effects on cerebral perfusion
  and oxygenation in adult SCD patients remain largely unexplored. This study investigated
  the effects of HSCT on cerebral blood flow (CBF), oxygen delivery, cerebrovascular
  reserve (CVR), oxygen extraction fraction (OEF), and cerebral metabolic rate of
  oxygen (CMRO2 ) in 17 adult SCD patients (mean age: 25.0 +- 8.0, 6 females) before
  and after HSCT and 10 healthy ethnicity-matched controls (mean age: 28.0 +- 8.8,
  6 females) using MRI. For the CVR assessment, perfusion scans were performed before
  and after acetazolamide as a vasodilatory stimulus. Following HSCT, gray and white
  matter (GM and WM) CBF decreased (p < .01), while GM and WM CVR increased (p < .01)
  compared with the baseline measures. OEF and CMRO2 also increased towards levels
  in healthy controls (p < .01). The normalization of cerebral perfusion and oxygen
  metabolism corresponded with a significant increase in hemoglobin levels and decreases
  in reticulocytes, total bilirubin, and LDH as markers of hemolysis (p < .01). This
  study shows that HSCT results in the normalization of cerebral perfusion and oxygen
  metabolism, even in adult patients with SCD. Future follow-up MRI scans will determine
  whether the observed normalization of cerebral hemodynamics and oxygen metabolism
  prevents new silent cerebral infarcts.'
raw_completion_output: |-
  primary_disease: Sickle cell disease

  medical_actions: Hematopoietic stem cell transplantation (HSCT); MRI scans; Perfusion scans with acetazolamide

  symptoms: Chronic hemolytic anemia; Impaired cerebral hemodynamics; Impaired oxygen metabolism

  chemicals: Acetazolamide

  action_annotation_relationships: Hematopoietic stem cell transplantation (HSCT) TREATS chronic hemolytic anemia IN Sickle cell disease; Hematopoietic stem cell transplantation (HSCT) TREATS impaired cerebral hemodynamics IN Sickle cell disease; Hematopoietic stem cell transplantation (HSCT) TREATS impaired oxygen metabolism IN Sickle cell disease; MRI scans TREATS impaired cerebral hemodynamics IN Sickle cell disease; MRI scans TREATS impaired oxygen metabolism IN Sickle cell disease; Perfusion scans with acetazolamide TREATS impaired cerebral hemodynamics IN Sickle cell disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Perfusion scans with acetazolamide TREATS impaired cerebral hemodynamics IN Sickle cell disease

  ===

extracted_object:
  primary_disease: MONDO:0011382
  medical_actions:
    - MAXO:0000747
    - MRI scans
    - Perfusion scans with acetazolamide
  symptoms:
    - HP:0004870
    - Impaired cerebral hemodynamics
    - Impaired oxygen metabolism
  chemicals:
    - CHEBI:27690
  action_annotation_relationships:
    - subject: MAXO:0000747
      predicate: TREATS
      object: HP:0004870
      qualifier: MONDO:0011382
    - subject: MAXO:0000747
      predicate: TREATS
      object: impaired cerebral hemodynamics
      qualifier: MONDO:0011382
    - subject: MAXO:0000747
      predicate: TREATS
      object: impaired oxygen metabolism
      qualifier: MONDO:0011382
    - subject: <MRI scans>
      predicate: <TREATS>
      object: <impaired cerebral hemodynamics>
      qualifier: <Sickle cell disease>
      subject_extension: <MRI scans>
    - subject: MRI scans
      predicate: TREATS
      object: impaired oxygen metabolism
      qualifier: MONDO:0011382
    - subject: Perfusion scans with acetazolamide
      predicate: TREATS
      object: impaired cerebral hemodynamics
      qualifier: MONDO:0011382
      subject_extension: CHEBI:27690
named_entities:
  - id: MONDO:0007374
    label: Sickle cell disease (SCD)
  - id: MAXO:0000457
    label: pain management
  - id: HP:0001903
    label: anemia
  - id: CHEBI:44423
    label: hydroxyurea
  - id: CHEBI:18050
    label: L-glutamine
  - id: MAXO:0000058
    label: pharmacotherapy
  - id: HP:0100602
    label: preeclampsia
  - id: HP:0001622
    label: preterm delivery
  - id: HP:0001511
    label: intrauterine growth restriction
  - id: CHEBI:50858
    label: corticosteroids
  - id: HP:0001907
    label: thromboembolism
  - id: MAXO:0000503
    label: Mechanical ventilation
  - id: MONDO:0011382
    label: Sickle Cell Disease
  - id: MAXO:0001001
    label: Gene therapies
  - id: HP:0025322
    label: VOD
  - id: CHEBI:82557
    label: Treosulfan
  - id: MAXO:0000750
    label: conditioning regimen
  - id: MONDO:0007885
    label: Osteonecrosis of the femoral head (AVNFH)
  - id: HP:0012531
    label: Pain
  - id: HP:0000969
    label: Oedema
  - id: MONDO:0018660
    label: hemophilia
  - id: HP:0012532
    label: Chronic pain
  - id: CHEBI:3216
    label: Buprenorphine
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation
  - id: HP:0100543
    label: cognitive dysfunction
  - id: HP:0000739
    label: anxiety
  - id: CHEBI:50131
    label: Decitabine
  - id: CHEBI:29548
    label: Cytidine deaminase (CDA)
  - id: MONDO:0009693
    label: Multiple Myeloma
  - id: CHEBI:145536
    label: Motixafortide
  - id: MAXO:0000601
    label: Dialysis
  - id: HP:0000083
    label: Kidney failure
  - id: MONDO:0100096
    label: COVID-19
  - id: MAXO:0001017
    label: vaccination
  - id: CHEBI:28901
    label: busulfan
  - id: CHEBI:9570
    label: thiotepa
  - id: MAXO:0000952
    label: Hydration therapy
  - id: HP:0006775
    label: Myeloma
  - id: MAXO:0000756
    label: blood transfusions
  - id: MONDO:0005570
    label: Hematologic diseases
  - id: HP:0007760
    label: Sickle cell disease (SCD)
  - id: MAXO:0010203
    label: echocardiography
  - id: CHEBI:31980
    label: Definity
  - id: MAXO:0000149
    label: Hematopoietic stem cell transplantation (HCT)
  - id: HP:0001297
    label: stroke
  - id: CHEBI:6716
    label: Depot medroxyprogesterone acetate
  - id: CHEBI:50114
    label: Estrogen
  - id: CHEBI:59826
    label: Progestin
  - id: MONDO:0005161
    label: Human papillomavirus (HPV)
  - id: MAXO:0000759
    label: HPV vaccination
  - id: MAXO:0000194
    label: opioid therapy
  - id: MAXO:0000882
    label: behavioral modification
  - id: MAXO:0001298
    label: therapy
  - id: MAXO:0010041
    label: skin grafting
  - id: MONDO:0044348
    label: Hemoglobinopathies
  - id: HP:0002092
    label: Pulmonary hypertension
  - id: MAXO:0000573
    label: use of assisted reproductive technologies (ART)
  - id: HP:0000044
    label: hypogonadotropic hypogonadism (HH)
  - id: HP:0009800
    label: gestational diabetes mellitus
  - id: HP:0011891
    label: post-partum haemorrhage
  - id: HP:0002617
    label: Vasculopathy
  - id: CHEBI:15365
    label: Aspirin
  - id: MAXO:0000068
    label: Transplantation
  - id: HP:0004870
    label: Chronic hemolytic anemia
  - id: CHEBI:27690
    label: Acetazolamide
